Cargando…
Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report
A 47-year-old man presented at the Ophthalmology Department of Saku City Asama General Hospital complaining of hyperemia and pain after industrial sodium hydroxide (approx. 40% concentration) had entered his left eye. With an epithelial defect of the bulbar and palpebral conjunctiva, ischemia of the...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342862/ https://www.ncbi.nlm.nih.gov/pubmed/25762927 http://dx.doi.org/10.1159/000369201 |
_version_ | 1782359330597634048 |
---|---|
author | Sasaki, Hidenori Kokubun, Takamichi |
author_facet | Sasaki, Hidenori Kokubun, Takamichi |
author_sort | Sasaki, Hidenori |
collection | PubMed |
description | A 47-year-old man presented at the Ophthalmology Department of Saku City Asama General Hospital complaining of hyperemia and pain after industrial sodium hydroxide (approx. 40% concentration) had entered his left eye. With an epithelial defect of the bulbar and palpebral conjunctiva, ischemia of the inferior third of the limbal conjunctiva, a total corneal epithelial defect and mild corneal stromal opacity, the damage was determined as Roper-Hall grade III. 2% rebamipide ophthalmic suspension, which is used for dry eye disease, was administered 4 times a day followed by conventional treatment for serious alkali injury. The corneal epithelial defect was resolved, and there were no side effects. The effectiveness of 2% rebamipide ophthalmic suspension in both the repair and improvement of the damage in the conjunctival and corneal epithelia, and its anti-inflammatory effect suggest that it may be an effective treatment not only for dry eye disease but also for alkali ocular damage. |
format | Online Article Text |
id | pubmed-4342862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-43428622015-03-11 Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report Sasaki, Hidenori Kokubun, Takamichi Case Rep Ophthalmol Published online: November, 2014 A 47-year-old man presented at the Ophthalmology Department of Saku City Asama General Hospital complaining of hyperemia and pain after industrial sodium hydroxide (approx. 40% concentration) had entered his left eye. With an epithelial defect of the bulbar and palpebral conjunctiva, ischemia of the inferior third of the limbal conjunctiva, a total corneal epithelial defect and mild corneal stromal opacity, the damage was determined as Roper-Hall grade III. 2% rebamipide ophthalmic suspension, which is used for dry eye disease, was administered 4 times a day followed by conventional treatment for serious alkali injury. The corneal epithelial defect was resolved, and there were no side effects. The effectiveness of 2% rebamipide ophthalmic suspension in both the repair and improvement of the damage in the conjunctival and corneal epithelia, and its anti-inflammatory effect suggest that it may be an effective treatment not only for dry eye disease but also for alkali ocular damage. S. Karger AG 2014-11-20 /pmc/articles/PMC4342862/ /pubmed/25762927 http://dx.doi.org/10.1159/000369201 Text en Copyright © 2014 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions. |
spellingShingle | Published online: November, 2014 Sasaki, Hidenori Kokubun, Takamichi Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report |
title | Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report |
title_full | Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report |
title_fullStr | Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report |
title_full_unstemmed | Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report |
title_short | Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report |
title_sort | alkali burn treated with 2% rebamipide ophthalmic suspension: a case report |
topic | Published online: November, 2014 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342862/ https://www.ncbi.nlm.nih.gov/pubmed/25762927 http://dx.doi.org/10.1159/000369201 |
work_keys_str_mv | AT sasakihidenori alkaliburntreatedwith2rebamipideophthalmicsuspensionacasereport AT kokubuntakamichi alkaliburntreatedwith2rebamipideophthalmicsuspensionacasereport |